Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (140)	7/11/1999 2:38:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 395

>> Interesting how cold hard cash get things done... the rest of the "DAN" protocol [diet and nystatin] is being totally ignored because there's little money involved. << While I know zip about autism..... lots of good therapies out there with no decent way to commercialize them. :-( What's more disturbing? The percentage of public-derived biotech funding that has gone to scam or "bait and switch" business plans. The good news?...... the companies that have gone belly-up this year -- or that have found themselves mortally wounded -- were among the worst offenders. It is reprehensible action to drive medical research funding into certain hands. I feel that contributions at SI are making a major impact on the recognition of "sound science/management" companies.